A. Pinna

894 total citations
9 papers, 143 citations indexed

About

A. Pinna is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Pinna has authored 9 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Pinna's work include Lymphoma Diagnosis and Treatment (5 papers), Neutropenia and Cancer Infections (3 papers) and Viral-associated cancers and disorders (3 papers). A. Pinna is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Neutropenia and Cancer Infections (3 papers) and Viral-associated cancers and disorders (3 papers). A. Pinna collaborates with scholars based in France, Netherlands and Slovenia. A. Pinna's co-authors include M. Henry‐Amar, John Raemaekers, Roberto Bortolus, T. Girinsky, Anton Hagenbeek, Richard W.M. van der Maazen, Yolande Lievens, Berthe M.P. Aleman, Marnix L.M. Lybeert and Patrice Carde and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

A. Pinna

9 papers receiving 141 citations

Peers

A. Pinna

PFM

PRM

ONCOL

NEURO

HEMAT

Catherine Crombie Australia

Lauris Gastaud France

Dick Johan van Spronsen Netherlands

Patricia Franchi France

Shalal Sadullah United Kingdom

Priya Sriskandarajah United Kingdom

R. Allerton United Kingdom

Víctor R. Pimentel-Quiroz Peru

Sandra Kessel United States

D. M. Green United States

Catherine Crombie Australia

A. Pinna

51 ×0.5

PFM

45 ×0.7

PRM

56 ×0.9

ONCOL

20 ×0.4

NEURO

11 ×0.5

HEMAT

Citations per year, relative to A. Pinna A. Pinna (= 1×) peers Catherine Crombie

Countries citing papers authored by A. Pinna

Since Specialization

Citations

This map shows the geographic impact of A. Pinna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pinna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pinna more than expected).

Fields of papers citing papers by A. Pinna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pinna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pinna. The network helps show where A. Pinna may publish in the future.

Co-authorship network of co-authors of A. Pinna

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pinna. A scholar is included among the top collaborators of A. Pinna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pinna. A. Pinna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Aleman, Berthe M.P., John Raemaekers, Margreet H.A. Baaijens, et al.. (2006). Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin’s lymphoma. International Journal of Radiation Oncology*Biology*Physics. 67(1). 19–30. 35 indexed citations

Aleman, Berthe M.P., T. Girinsky, Richard W.M. van der Maazen, et al.. (2005). Quality control of involved-field radiotherapy in patients with advanced Hodgkin’s lymphoma (EORTC 20884). International Journal of Radiation Oncology*Biology*Physics. 63(4). 1184–1190. 18 indexed citations

Valteau-Couanet, D, Catherine Faucher, A. Aupérin, et al.. (2005). Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial. Bone Marrow Transplantation. 36(6). 547–552. 30 indexed citations

Aleman, Berthe M.P., M. Henry‐Amar, Umberto Tirelli, et al.. (2001). Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884. Blood. 98(11). 6 indexed citations

Aupérin, A., Chiara Capelli, E Benhamou, et al.. (1997). PP5. Teicoplanin or vancomycin in febrile neutropenic children with cancer: A randomized cost effectiveness study. European Journal of Cancer. 33. S16–S16. 2 indexed citations

Aupérin, A., Carlo Cappelli, E Benhamou, et al.. (1997). Teicoplanine ou vancomycine chez l'enfant en granulopénie fébrile post chimiothérapie : une étude randomisée coût efficacité. Médecine et Maladies Infectieuses. 27. 984–988. 3 indexed citations

Raemaekers, John, M. Henry‐Amar, A. Pinna, et al.. (1997). . Annals of Oncology. 8(1+). 111–114. 7 indexed citations

Raemaekers, John, M Burgers, M. Henry‐Amar, et al.. (1997). Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC phase III trial. Annals of Oncology. 8. S111–S114. 26 indexed citations

Raemaekers, John, M Burgers, M. Henry‐Amar, et al.. (1997). Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.. PubMed. 8 Suppl 1. 111–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact